Tatsis Ourania sold VRTX
February 21, 2024 · Form 4 insider transaction
Tatsis Ourania sold 360 shares of Vertex Pharmaceuticals Incorporated at $421.77 per share, a transaction worth $151.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
360
Price
$421.77
Total value
$151.8K
InsiderTatsis Ourania
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 21, 2024
Filing dateFebruary 23, 2024
Shares owned after59,467
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023.